Relapsed Chronic Lymphocytic Leukemia

Also known as: Chronic, relapsed Lymphocytic Leukemia / Relapse Chronic lymphocytic leukemia / Relapsed CLL

DrugDrug NameDrug Description
DB09054IdelalisibAn antineoplastic kinase inhibitor used to treat chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL).
DrugDrug NamePhaseStatusCount
DB00531Cyclophosphamide0Active Not Recruiting1
DB00091Cyclosporine0Active Not Recruiting1
DB01073Fludarabine0Active Not Recruiting1
DB00688Mycophenolate mofetil0Active Not Recruiting1
DB00531Cyclophosphamide1Not Yet Recruiting1
DB01073Fludarabine1Not Yet Recruiting1
DB00531Cyclophosphamide2Recruiting1
DB01590Everolimus2Recruiting1
DB01073Fludarabine2Recruiting2
DB01042Melphalan2Recruiting1
DB00331Metformin2Suspended1
DB00688Mycophenolate mofetil2Recruiting1
DB08910Pomalidomide2Recruiting1
DB00877Sirolimus2Recruiting1